ProKidney Corp. – NASDAQ:PROK
ProKidney Corp. stock price today
$2.32
+0.61
+36.47%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 6 hours
ProKidney Corp. stock price monthly change
-27.66%
month
ProKidney Corp. stock price quarterly change
-27.66%
quarter
ProKidney Corp. stock price yearly change
-19.81%
year
ProKidney Corp. key metrics
Market Cap | 472.57M |
Enterprise value | 194.75M |
P/E | -55.5 |
EV/Sales | N/A |
EV/EBITDA | -1.92 |
Price/Sales | N/A |
Price/Book | -0.62 |
PEG ratio | 0.11 |
EPS | -0.89 |
Revenue | N/A |
EBITDA | -125.50M |
Income | -55.31M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeProKidney Corp. stock price history
ProKidney Corp. stock forecast
ProKidney Corp. financial statements
| Jun 2023 | 0 | -9.11M | |
|---|---|---|---|
| Sep 2023 | 0 | -31.00M | |
| Dec 2023 | 4.49M | -5.70M | -126.86% |
| Mar 2024 | 0 | -9.49M |
| 2025 | 0 | -40.06M | |
|---|---|---|---|
| 2026 | 0 | -56.82M |
Analysts Price target
Financials & Ratios estimates
| 2024-03-21 | -0.19 | -0.09 |
|---|---|---|
| 2024-05-10 | -0.25 | -0.16 |
| Jun 2023 | 484221000 | 27.27M | 5.63% |
|---|---|---|---|
| Sep 2023 | 451806000 | 23.61M | 5.23% |
| Dec 2023 | 420552000 | 29.21M | 6.95% |
| Mar 2024 | 387763000 | 24.72M | 6.38% |
| Jun 2023 | -14.91M | -13.15M | -13K |
|---|---|---|---|
| Sep 2023 | -23.77M | -28.37M | -13K |
| Dec 2023 | -25.38M | -95.84M | -9.51M |
| Mar 2024 | -34.64M | 58.39M | -13K |
ProKidney Corp. alternative data
| Aug 2023 | 87 |
|---|---|
| Sep 2023 | 87 |
| Oct 2023 | 87 |
| Nov 2023 | 87 |
| Dec 2023 | 87 |
| Jan 2024 | 87 |
| Feb 2024 | 87 |
| Mar 2024 | 163 |
| Apr 2024 | 163 |
| May 2024 | 163 |
| Jun 2024 | 163 |
| Jul 2024 | 163 |
ProKidney Corp. other data
27.75%
-72.25%
of PROK is owned by hedge funds
17.07M
-14.35M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2023 | 0 | 1700000 |
| Oct 2023 | 0 | 2371900 |
| Nov 2023 | 0 | 4017733 |
| Apr 2024 | 0 | 118879 |
| May 2024 | 0 | 17238 |
| Jun 2024 | 22617909 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | LEGORRETA PABLO G. director, 10 perc.. | Class A Ordinary Shares | 22,617,909 | $2.42 | $54,735,340 | ||
Sale | WEBER DARIN J. officer: Chief Regulatory Officer | Class A Ordinary Shares | 17,238 | $4.08 | $70,383 | ||
Sale | WEBER DARIN J. officer: SVP of Regulatory Deve.. | Class A Ordinary Shares | 16,438 | $2.51 | $41,309 | ||
Sale | WEBER DARIN J. officer: SVP of Regulatory Deve.. | Class A Ordinary Shares | 800 | $2.54 | $2,028 | ||
Sale | WEBER DARIN J. officer: SVP of Regulatory Deve.. | Class A Ordinary Shares | 17,238 | $2.5 | $43,095 | ||
Sale | WEBER DARIN J. officer: SVP of Regulatory Deve.. | Class A Ordinary Shares | 84,103 | $1.73 | $145,498 | ||
Sale | WEBER DARIN J. officer: SVP of Regulatory Deve.. | Class A Ordinary Shares | 300 | $1.69 | $507 | ||
Sale | PALIHAPITIYA CHAMATH | Class A ordinary shares | 2,073,000 | $1.31 | $2,713,557 | ||
Sale | PALIHAPITIYA CHAMATH 10 percent owner | Class A ordinary shares | 258,400 | $1.19 | $308,530 | ||
Sale | PALIHAPITIYA CHAMATH 10 percent owner | Class A ordinary shares | 212,100 | $1.22 | $259,398 |
| Quarter | Transcript |
|---|---|
| Q3 2023 16 Nov 2023 | Q3 2023 Earnings Call Transcript |
-
What's the price of ProKidney Corp. stock today?
One share of ProKidney Corp. stock can currently be purchased for approximately $2.32.
-
When is ProKidney Corp.'s next earnings date?
Unfortunately, ProKidney Corp.'s (PROK) next earnings date is currently unknown.
-
Does ProKidney Corp. pay dividends?
No, ProKidney Corp. does not pay dividends.
-
How much money does ProKidney Corp. make?
ProKidney Corp. has a market capitalization of 472.57M. ProKidney Corp. made a loss 35.47M US dollars in net income (profit) last year or -$0.16 on an earnings per share basis.
-
What is ProKidney Corp.'s stock symbol?
ProKidney Corp. is traded on the NASDAQ under the ticker symbol "PROK".
-
What is ProKidney Corp.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of ProKidney Corp.?
Shares of ProKidney Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does ProKidney Corp. have?
As Jul 2024, ProKidney Corp. employs 163 workers.
-
When ProKidney Corp. went public?
ProKidney Corp. is publicly traded company for more then 4 years since IPO on 30 Jun 2021.
-
What is ProKidney Corp.'s official website?
The official website for ProKidney Corp. is prokidney.com.
-
Where are ProKidney Corp.'s headquarters?
ProKidney Corp. is headquartered at 2000 Frontis Plaza Blvd., Winston-Salem, NC.
-
How can i contact ProKidney Corp.?
ProKidney Corp.'s mailing address is 2000 Frontis Plaza Blvd., Winston-Salem, NC and company can be reached via phone at +33 69997028.
ProKidney Corp. company profile:
ProKidney Corp.
prokidney.comExchange:
NASDAQ
Full time employees:
163
Industry:
Biotechnology
Sector:
Healthcare
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
2000 Frontis Plaza Blvd.
Winston-Salem, NC 27103
Winston-Salem, NC 27103
CIK: 0001850270
ISIN: KYG7S53R1049
:
